Who owns the GAVRETO trademark?

The GAVRETO trademark is owned by Blueprint Medicines Corporation.

What class is the GAVRETO trademark registered in?

The GAVRETO trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for GAVRETO?

The USPTO serial number for GAVRETO is 90025140.

What is the registration number for GAVRETO?

GAVRETO is registered under USPTO registration number 0.

Sealvo

Home Search: GAVRETOGAVRETO #90025140

Back

Updated Oct 5, 2026·23 searches this week

View on USPTO TSDR Find similar marks

GAV

USPTO Trademark Record

ABANDONED

GAVRETO

SN 90025140·Reg 0·Filed Jun 29, 2020

Owner Blueprint Medicines Corporation

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

GAVRETO (Serial No. 90025140), Registration No. 0, is a abandoned US trademark filed on Jun 29, 2020 by Blueprint Medicines Corporation. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Mark Intelligence

GAVRETO (Reg. #0) is an abandoned US trademark that was filed in 2020 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jun 29, 2020

SERIAL

90025140

REG#

Filing Information

StatusABANDONED

Filing DateJun 29, 2020

Serial Number90025140

Registration No.0

Status DateFeb 23, 2022

Published for OppositionNov 10, 2020

Mark TypeDesign with words

Filing Basis & Declarations

Trademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Sep 14, 2020

First use in commerce: Sep 14, 2020

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

24 events

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Feb 23, 2022

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Feb 23, 2022

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

NOTIFICATION OF FINAL REFUSAL EMAILED

Aug 10, 2021

NOTIFICATION OF FINAL REFUSAL EMAILED

FINAL REFUSAL E-MAILED

Aug 10, 2021

FINAL REFUSAL E-MAILED

SU - FINAL REFUSAL - WRITTEN

Aug 10, 2021

SU - FINAL REFUSAL - WRITTEN

TEAS/EMAIL CORRESPONDENCE ENTERED

Jun 26, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jun 25, 2021

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jun 25, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION E-MAILED

May 10, 2021

NON-FINAL ACTION E-MAILED

SU - NON-FINAL ACTION - WRITTEN

May 10, 2021

SU - NON-FINAL ACTION - WRITTEN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

May 10, 2021

NOTIFICATION OF NON-FINAL ACTION E-MAILED

STATEMENT OF USE PROCESSING COMPLETE

Apr 06, 2021

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Apr 06, 2021

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS STATEMENT OF USE RECEIVED

Mar 21, 2021

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Mar 21, 2021

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jan 05, 2021

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Nov 10, 2020

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Nov 10, 2020

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Oct 21, 2020

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Oct 07, 2020

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Oct 01, 2020

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

Jul 25, 2020

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 24, 2020

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jul 02, 2020

NEW APPLICATION ENTERED

Other Marks by Blueprint Medicines Corporation

Additional USPTO filings from the same owner.

LOG

LogoMark

88640785

Blueprint Medicines Corporation

REGISTERED

AYV

AYVAKIT

88589364

Blueprint Medicines Corporation

REGISTERED

YOU

YOUR BLUEPRINT

88376992

Blueprint Medicines Corporation

REGISTERED

AYV

AYVAKIT

88478478

Blueprint Medicines Corporation

REGISTERED

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Recently filed and registered marks in the same international class.

GAV

GAVRETO

88492520

RIGEL PHARMACEUTICALS, INC.

REGISTERED

Other Marks by Timothy H. Hiebert

Additional USPTO filings handled by the same attorney of record.

POW

POWER OVER AHP GLOBAL PERSPECTIVES ON LIVING WITH ACUTE HEPATIC PORPHYRIA

97081087

REGISTERED

97207472

REGISTERED

NFP

NFPA 5000

78145684

REGISTERED

CAP

CAPTERRA

90286611

REGISTERED

GAVRETO

Run a conflict check

Other Marks by Blueprint Medicines Corporation

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Timothy H. Hiebert

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company